BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report)’s stock price dropped 1.3% on Friday . The stock traded as low as $11.24 and last traded at $11.25. 3,188 shares traded hands during mid-day trading, an increase of 25% from the average session volume of 2,541 shares. The stock had previously closed at $11.40.
BioSyent Stock Performance
The business’s 50-day moving average is $10.92 and its two-hundred day moving average is $10.67.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Featured Articles
- Five stocks we like better than BioSyent
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
